SCHEMBL30715237

SCHEMBL30715237

CN(C)C(=O)c1ccc2cn[nH]c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.51
MAPT P10636 3/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 1/20 0.49
DYRK1A Q13627 3/20 0.48
MAP4K4 O95819 1/20 0.48
CLK2 P49760 1/20 0.48
SRPK1 Q96SB4 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
ROCK2 O75116 1/20 0.48
ROCK1 Q13464 1/20 0.48
AR P10275 1/20 0.46
NOS1 P29475 3/20 0.46
MEN1 O00255 1/20 0.46
PKM P14618 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
METAP2 P50579 1/20 0.46
FGFR1 P11362 2/20 0.45
FGFR2 P21802 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5409208 0.87 ROCK2 (0.58) MAOBDYRK1AMAP4K4CLK2CLK4
SCHEMBL2933207 0.81 MAPT (0.68) MAOBMAPTKDM4EALDH1A1DYRK1A
SCHEMBL30194367 0.81 MAPT (0.68) MAOBMAPTKDM4EALDH1A1DYRK1A
SCHEMBL260992 0.80 ALDH1A1 (0.56) MAOBMAPTKDM4EALDH1A1DYRK1A
SCHEMBL29365815 0.80 ALDH1A1 (0.56) MAOBMAPTKDM4EALDH1A1DYRK1A
SCHEMBL22259503 0.79 GSK3B (0.56) MAOBDYRK1ACLK2CLK4ROCK2
SCHEMBL21004185 0.79 MAOB (0.52) MAOBMAPTKDM4EALDH1A1DYRK1A
SCHEMBL22221023 0.79 MAPK14 (0.47) MAPTKDM4EALDH1A1DYRK1ACLK2
SCHEMBL20187143 0.78 MAOB (0.58) MAOBMAPTKDM4EALDH1A1DYRK1A
SCHEMBL7378385 0.78 MAOB (0.55) MAOBMAPTKDM4EALDH1A1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117460508-A Combination therapy comprising a METTL3 inhibitor and an additional anticancer agent 斯托姆治疗有限公司 2024-01-26 CN disclosed